The European Parliament
should be "central" to any decision on the new venue for the
European Medicines Agency (EMA), which is moving from London
after Brexit, EP Presint Antonio Tajani said Monday.
"I claim the central nature of the European Parliament in the
decision on the new seat of the medicines agency," he said.
Italy and Milan have appealed against last year's decision to
move the EMA to Amsterdam, amid concerns the office there may
not be ready.
Tajani said "in order to change seat you need to reform the
regulation, and to reform the regulation you need an ordinary
legislative procedure which is in course. We'll see what the
EP's environmental committee decides, and we'll see what the
sovereign assembly decides, which will certainly work in the
interests of European citizens".
Milan lost out to Amsterdam in a tie-break lottery after
ending up with the same votes at an EU ministers' meeting on
November 20.
photo: temporary EMA HQ in Amsterdam
ALL RIGHTS RESERVED © Copyright ANSA
